ACTA1 and melanoma: Conversely, Ad-HDGF shRNA infection potentiated protein level and the promoter activity of E-cadherin, and reduced the protein levels of vimentin and α-SMA in B16–F10 melanoma cells (Fig 5B and Fig. S1B).